FDA Inspection 1244675 — Carter Bloodcare - Weatherford

Carter Bloodcare - Weatherford — FEI 3008054449

The FDA completed an inspection of Carter Bloodcare - Weatherford on July 10, 2024 in Weatherford, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 10, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Weatherford, TX (United States)